| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 04/07/1993 | EP0535007A1 A MONOCLONAL ANTIBODY AGAINST THE GAG PROTEIN PRECURSOR p55 OF HUMAN IMMUNODEFICIENCY VIRUS. |
| 04/07/1993 | EP0233936B1 Synthetic polypeptides for detecting mycobacterial infections |
| 04/07/1993 | EP0215110B1 Production of human somatomedin c |
| 04/06/1993 | US5200510 Utilizing a preferential binding peptide bound to an insoluble matrix; elution; collection |
| 04/01/1993 | WO1993006231A1 Anti-human milk fat globule humanised antibodies |
| 04/01/1993 | WO1993006213A1 Production of chimeric antibodies - a combinatorial approach |
| 04/01/1993 | WO1993006135A1 Diagnosing and treating autoimmune disorders |
| 04/01/1993 | WO1993006134A1 Factors for the cellular functional regulation and biological applications thereof |
| 04/01/1993 | WO1993006131A1 Porcine adipocyte antigens and their use in the immunological control of fat |
| 04/01/1993 | WO1993005751A2 Osteogenic proteins in the treatment of bone deseases |
| 04/01/1993 | WO1992022583A3 Tri- and tetra-valent monospecific antigen-binding proteins |
| 04/01/1993 | CA2119003A1 Factors for the cellular functional regulation and biological applications thereof |
| 04/01/1993 | CA2116033A1 Porcine adipocyte antigens and their use in the immunological control of fat |
| 03/31/1993 | EP0534878A1 Recombinant DNA molecules containing the coding part of a VBeta17 chain of the T cell antigen receptor and uses thereof |
| 03/31/1993 | EP0534742A1 Anti-human milk fat globule humanised antibodies |
| 03/31/1993 | EP0534618A2 Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus |
| 03/31/1993 | EP0534615A2 HLA-restricted hepatitis B virus CTL epitopes |
| 03/31/1993 | EP0534568A2 Human growth hormone analogues and their use |
| 03/31/1993 | EP0533830A1 Measuring non-dystrophin proteins and diagnosing muscular dystrophy |
| 03/30/1993 | CA1315470C Allylic side chain-containing solid phase systems, processes for the preparation thereof and the use thereof in solid phase reactions |
| 03/30/1993 | CA1315225C Polypeptide useful for the allevation, treatment and diagnosis of auto-immune diseases, especially arthritic conditions, etc. |
| 03/27/1993 | CA2079197A1 Recombinant nda new molecules containing the codifying part of a vbeta 17 chain for the t-cells antigene receptor, preparat ion process, antibodies and drugs containing them |
| 03/24/1993 | EP0533199A2 Application to a chimeric antibody directed against ganglioside GD3 |
| 03/24/1993 | EP0533006A1 Chimaeric interleukin 5-receptor/immunoglobulin polypeptides |
| 03/24/1993 | EP0532587A1 Methods for trans-destabilization of specific proteins in vivo |
| 03/24/1993 | EP0532525A1 New protein-polycation conjugates. |
| 03/24/1993 | EP0345315B1 Ps2 protein derivative |
| 03/24/1993 | EP0134799B1 Expression of plasmodium falciparum polypeptides from cloned cdna |
| 03/23/1993 | US5196510 Polypeptides |
| 03/23/1993 | US5196308 Methods for identifying the DQw3.2 allele associated with increased risk of insulin-dependent diabetes mellitus |
| 03/23/1993 | CA1314830C Bar1 secretion signal |
| 03/23/1993 | CA1314811C Methods for identifying alleles associated with increased risk of diabetes |
| 03/23/1993 | CA1314810C Heterologous system for the detection of chemically-labeled dna and other biological materials providing a receptor or target moiety thereon |
| 03/19/1993 | CA2078384A1 Chimaeric interleukin 5-receptor/immunoglobulin polypeptides |
| 03/18/1993 | WO1993005169A1 Hybrid cytokines |
| 03/18/1993 | WO1993004700A1 Vα12.1 T-CELL RECEPTOR-SPECIFIC REAGENTS FOR DIAGNOSING AND TREATING RHEUMATOID ARTHRITIS |
| 03/18/1993 | CA2116533A1 Hybrid cytokines |
| 03/18/1993 | CA2116339A1 V.alpha.12.1 t-cell receptor-specific reagents for diagnosing and treating rheumatoid arthritis |
| 03/17/1993 | EP0532090A2 Cellular immunity vaccines from bacterial toxin-antigen conjugates |
| 03/17/1993 | EP0531472A1 Humanized and chimeric monoclonal antibodies |
| 03/17/1993 | EP0531434A1 Improved pseudomonas exotoxins of low animal toxicity and high cytocidal activity |
| 03/17/1993 | EP0531407A1 Analogs of glycoprotein hormones having altered immunological characteristics, efficacy and/or receptor specificity |
| 03/16/1993 | US5194596 Production of vascular endothelial cell growth factor |
| 03/16/1993 | US5194425 Mhc-mediated toxic conjugates useful in ameliorating autoimmunity |
| 03/10/1993 | EP0530447A2 Process for purifying IgG monoclonal antibodies and their use |
| 03/10/1993 | CA2077277A1 Cellular immunity vaccines from bacterial toxin-antigen conjugates |
| 03/04/1993 | WO1993004175A1 Osp a proteins of borrelia burgdorferi subgroups, encoding genes and vaccines |
| 03/04/1993 | WO1993004173A1 Immunoglobulin variants for specific fc epsilon receptors |
| 03/04/1993 | WO1993004089A1 Hepatitis c assay utilizing recombinant antigens from ns5 region |
| 03/04/1993 | WO1993004088A1 Hepatitis c assay utilizing recombinant antigens to ns1 |
| 03/04/1993 | WO1993004087A1 Hepatitis c assay utilizing recombinant antigens to c-100 region |
| 03/04/1993 | WO1993004084A1 Monoclonal antibodies to putative hcv ns5 proteins and methos for using same |
| 03/04/1993 | WO1993003764A1 Hla-restricted hepatitis b virus ctl epitopes |
| 03/04/1993 | WO1993003753A1 Peptides for inducing cytotoxic t-lymphocyte responses to hepatitis b virus |
| 03/04/1993 | CA2115926A1 Hepatitis c assay utilizing recombinant antigens to ns1 |
| 03/04/1993 | CA2115925A1 Hepatitis c assay utilizing recombinant antigens from ns5 region |
| 03/04/1993 | CA2115554A1 Osp a proteins of borrelia burgdorferi subgroups, encoding genes and vaccines |
| 03/03/1993 | EP0529075A1 Hybrid calcitonin |
| 03/03/1993 | EP0529065A1 Receptor-based screening methods for amylin agonists and antagonists |
| 03/03/1993 | EP0528931A1 Humanized chimeric anti-icam-1 antibodies, methods of preparation and use |
| 03/03/1993 | EP0528926A1 Soluble peptide analogues containing binding sites |
| 03/03/1993 | EP0517805A4 Identification and expression of insect steroid receptor dna sequences |
| 03/03/1993 | CN1069522A Intercellular adhesion molecule-3 and its binding ligands |
| 03/01/1993 | WO1993005152A1 Antibodies to streptolysin o derivatives and variants |
| 03/01/1993 | CA2094242A1 Antibodies to streptolysin o derivatives and variants |
| 02/24/1993 | EP0528527A2 Conjugates |
| 02/24/1993 | EP0528011A1 CD4-GAMMA2 AND CD4-IgG2 CHIMERAS |
| 02/24/1993 | EP0527954A1 Molecular recognition units |
| 02/24/1993 | EP0527839A1 Recombinant library screening methods |
| 02/24/1993 | EP0527785A1 Improvements relating to the detection of viruses |
| 02/24/1993 | EP0527778A1 Improved process of purifying recombinant proteins and compounds useful in such process. |
| 02/24/1993 | EP0527767A1 Self-polymerising expression system based on modified potyvirus coat proteins |
| 02/23/1993 | CA1313831C Method of generating desired aminoterminal residues in proteins and methods of regulating metabolic stability of proteins |
| 02/18/1993 | WO1993003151A1 Treatment of cell populations |
| 02/18/1993 | WO1993003057A1 Polypeptides capable of in vivo induction of antibodies themselves capable of inhibiting the invasion of red blood corpuscles by merozoites of p.falciparum, related products and their use in producing vaccine compositions |
| 02/18/1993 | WO1993003050A1 Novel cyclophilins, associating proteins and uses |
| 02/18/1993 | WO1993002691A1 Steroid hormone drug delivery |
| 02/18/1993 | CA2114950A1 Treatment of cell populations |
| 02/18/1993 | CA2114942A1 Novel cyclophilins, associating proteins and uses |
| 02/18/1993 | CA2114223A1 Polypeptides capable of in vivo induction of antibodies themselves capable of inhibiting the invasion of red blood corpuscles by merozoites of p. falciparum, related products and their use in producing vaccine compositions |
| 02/16/1993 | US5187261 Peptide sequence of first seven amino acids of lambda bacteriophage protein fused to human serum albumin |
| 02/16/1993 | US5187153 Methods of treatment using Alzheimer's amyloid polypeptide derivatives |
| 02/16/1993 | US5187087 Recominbant herpesvirus of turkeys and live vector vaccines derived thereof |
| 02/16/1993 | US5187063 Combining a muscle sample with antibodies which specifically bind to glycoprotein component of dystrophin/glycoprotein complex, detecing extent of binding and comparing with extent of binding in nondystrophic muscle tissue samples |
| 02/10/1993 | EP0527063A1 Production of protein of interest in the milk of transgenic mammal |
| 02/10/1993 | EP0526953A1 Multichain polypeptides or proteins and processes for their production |
| 02/10/1993 | EP0526952A2 Soluble interleukin-2 receptor as a disease indicator and a method of assaying the same |
| 02/10/1993 | EP0526452A1 Hybrid immunoglobulins |
| 02/10/1993 | EP0402415B1 Synthetic scm-active cancer recognition peptides |
| 02/03/1993 | EP0525054A1 Modified heparin binding growth factors |
| 02/03/1993 | EP0386076B1 Phosphoryled derivatives of cardiodilatine/anf peptides |
| 02/03/1993 | CN1068501A A-c-b proinsulin, method of manufacturing and using same, and intermediates in insulin production |
| 01/27/1993 | EP0524583A1 Procedure and means for the turbidimetric or nephelometric determination of analyses |
| 01/27/1993 | EP0348442B1 Altered antibody |
| 01/27/1993 | CN1068335A Hepatitis c diagnostics and vaccines |
| 01/26/1993 | US5182260 Dna sequences encoding snake venom inhibitors of platelet activation processes for producing those inhibitors and compositions using them |
| 01/24/1993 | CA2074345A1 Method and agent for the turbidimetric or nephelometric determination of analytes |
| 01/20/1993 | EP0523395A2 Seroreactive domains from the HPV 16 E1 and E2 proteins |
| 01/19/1993 | US5180811 Proteins having a tnf action comprising tnf-fibromectin fusion protein |
| 01/13/1993 | EP0522169A1 Antihuman stromelysin monoclonal antibody and diagnosis of rheumatoid arthritis by enzyme immunoassay |